Skip to main content
Skip to main content
PNTG logo

The Pennant Group, Inc. (PNTG) Stock Analysis

Educational signal · not a buy or sell recommendation · How to read this

$39.07 -$0.5257 (-1.33%) |Strong · 69
The Pennant Group, Inc. (PNTG) bottom line: Bullish Lean — our Council read (59/100) and AI Score (69/100) broadly agree. Strongest signal: Growth Durability strong · Biggest watch-out: Seth Klarman bearish.Educational signal, not a buy or sell recommendation. Compare sector peers → · Read the method →
MCap: $1.36B| P/E Ratio: 41.81| Vol: 77.3K| Target: $44.50 (+13.9%) (Aug 25, 2026) (estimate, not advice)| 52-wk range: $22.25 – $42.69

P/E 41.81 means the share price is 41.81 times one year of earnings per share; the S&P 500 usually sits near 20-25. Market cap $1.36B is the value of all shares combined.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

The Pennant Group, Inc. (PNTG) trades at $39.07 with MoonshotScore 69/100 (Grade B+). The Pennant Group, Inc. provides healthcare services, including home health, hospice, and senior living, across 14 states. Market cap: $1.36B, Sector: Healthcare.

Price as of Sep 10, 2026 · Last analyzed: May 10, 2026
The Pennant Group, Inc. provides healthcare services, including home health, hospice, and senior living, across 14 states. As of December 31, 2021, they operated 88 home health and hospice agencies and 54 senior living communities.

PNTG stock analysis for 2026: Analysts have set a consensus price target of $44.50 for The Pennant Group, Inc., suggesting 13.9% upside from the current price of $39.07. The AI MoonshotScore is 69/100, in the Strong band (65-79) — a research signal, not a recommendation. Key factors: analyst coverage, AI-driven quantitative scoring.

Watch the PNTG film Every key number, told as a short cinematic story — just press play. ~2 min

These figures come from statements filed 12 months ago — the most recent this company has published.

Council Score · Weighted Average of 3 Disciplines
Bullish Lean 59/100 · B

PNTG: 1/3 scored disciplines lean bullish. Dominant signal: Growth Durability strong.

How is this calculated? →
MoonshotScore · Five-pillar engine · 69/100
Business Quality
Moderate Is this a genuinely good business?
Financial Safety
Weak Could this blow up on me?
Valuation
Moderate Am I paying a fair price?
Growth Durability
Strong Is the growth real and likely to last?
Momentum
Moderate Is the market already moving on this?

Strongest side: Growth Durability (9/10, Strong). Weakest side: Financial Safety (2/10, Weak).

Legends Council · 5 Legends + Moon AI

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated)Ray Dalio
Favorable read
Griffin-style lens (simulated)Ken Griffin
Neutral read
Simons-style lens (simulated)Jim Simons
Favorable read
Englander-style lens (simulated)Izzy Englander
Neutral read
Klarman-style lens (simulated)Seth Klarman
Unfavorable read
Moon AI lens (model)
Favorable read
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Neutral
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →
The lenses are modelled on the published principles of the investors named. We are not affiliated with them, they have not endorsed this, and it is not their opinion of this stock.

Why this analysis is different

  • A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
  • An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
  • Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

The Pennant Group, Inc. (PNTG) Healthcare & Pipeline Overview

CEOBrent J. Guerisoli
Employees9,700
HeadquartersEagle, ID, US
IPO Year2019

The Pennant Group, Inc. operates within the healthcare sector, focusing on home health, hospice, and senior living services across 14 states. With a market capitalization of $1.36B and a P/E ratio of 41.81, Pennant distinguishes itself through its integrated care model and geographic diversification in the fragmented healthcare services market.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: May 10, 2026

What Is the Investment Thesis for PNTG?

AI-written as of May 10, 2026 — figures and tone reflect the data available then, not today's score.

With a market capitalization of $1.36B and a P/E ratio of 41.81, Pennant's growth is underpinned by the increasing demand for home health, hospice, and senior living services. Key value drivers include the expansion of its agency and community network, enhanced operational efficiencies, and the ability to capitalize on favorable demographic trends. A gross margin of 14.8% and a profit margin of 3.0% indicate areas for potential improvement through economies of scale and optimized service delivery. Upcoming catalysts include continued acquisitions and organic growth initiatives, while potential risks involve regulatory changes and competitive pressures within the healthcare sector.

Based on FMP financials and quantitative analysis

PNTG Key Highlights

AI-written as of May 10, 2026 — figures and tone reflect the data available then, not today's score.

Market capitalization of $1.36B, reflecting investor confidence in Pennant's growth strategy.

  • P/E ratio of 41.81, indicating a premium valuation relative to earnings.
  • Gross margin of 14.8%, highlighting the need for improved operational efficiency.
  • Profit margin of 3.0%, suggesting opportunities for margin expansion through cost management.
  • Operates 88 home health and hospice agencies and 54 senior living communities across 14 states, showcasing geographic diversification.

Who Are PNTG's Competitors?

PNTG is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
LHCG LHC Group, Inc. $169.81 0.00% $5.29B
AMED Amedisys, Inc. $100.99 +0.01% $3.32B
FIVE Five Below, Inc. $241.28 -2.36% $13.3B 895-pillar
AMN AMN Healthcare Services, Inc. $33.05 -3.81% $1.28B 935-pillar
LWSCF Sienna Senior Living Inc. $14.74 0.00% $1.46B 499-signal
INNV InnovAge Holding Corp. $10.81 -2.01% $1.47B 395-pillar
HCSG Healthcare Services Group, Inc. $21.84 -0.86% $1.50B 935-pillar
AGL Agilon Health, Inc. $92.60 -1.06% $1.54B 335-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are PNTG's Key Strengths?

Diversified service offerings across home health, hospice, and senior living.

  • Geographic presence in multiple states.
  • Experienced management team with a track record of growth.
  • Strong relationships with healthcare providers and payers.

What Are PNTG's Weaknesses?

Relatively low gross and profit margins compared to industry peers.

  • High reliance on government reimbursements.
  • Exposure to regulatory changes and compliance risks.
  • Competition from larger, more established players.

What Could Drive PNTG Stock Higher?

Continued acquisitions of home health, hospice, and senior living agencies to expand market presence.

  • Implementation of technology solutions to improve operational efficiency and patient care.
  • Expansion of value-based care initiatives to enhance reimbursement rates and patient outcomes.

What Are the Key Risks for PNTG?

Rich valuation — a P/E of 41.81 runs well above the Healthcare sector’s ~21.50x, leaving little room for a miss.

  • Changes in government reimbursement policies could negatively impact revenue and profitability.
  • Increased competition from other healthcare providers could erode market share.
  • Rising labor costs and workforce shortages could strain financial performance.

What Are the Growth Opportunities for PNTG?

  • Expansion of Home Health and Hospice Services: The market for home health and hospice services is projected to grow significantly, driven by the aging population and increasing preference for in-home care. Pennant can capitalize on this trend by expanding its agency network and service offerings in existing and new geographic markets. This expansion can be achieved through strategic acquisitions and organic growth initiatives, enhancing its market share and revenue streams. The timeline for this growth is ongoing, with continuous efforts to identify and integrate new agencies.
  • Enhancement of Senior Living Services: The demand for senior living communities is also on the rise, driven by the increasing number of seniors requiring residential accommodations and assistance with daily living activities. Pennant can enhance its senior living services by expanding its community network, improving the quality of care, and offering specialized programs tailored to the needs of seniors. This includes investing in facility upgrades, staff training, and innovative care models. The timeline for this growth is ongoing, with a focus on long-term sustainability and resident satisfaction.
  • Strategic Acquisitions: Pennant has a proven track record of successfully acquiring and integrating home health, hospice, and senior living agencies and communities. Strategic acquisitions provide opportunities to expand its geographic footprint, enhance its service offerings, and achieve economies of scale. Pennant can continue to pursue strategic acquisitions in attractive markets, leveraging its operational expertise and financial resources to drive growth and profitability. The timeline for this growth is ongoing, with a focus on identifying and evaluating potential acquisition targets.
  • Technological Innovation: Investing in technological innovation can improve operational efficiency, enhance the quality of care, and differentiate Pennant from its competitors. This includes implementing electronic health records (EHRs), telehealth solutions, and data analytics tools to streamline workflows, improve patient outcomes, and optimize resource allocation. By leveraging technology, Pennant can reduce costs, improve service delivery, and gain a competitive advantage. The timeline for this growth is ongoing, with a focus on continuous improvement and innovation.
  • Value-Based Care Initiatives: As the healthcare industry shifts towards value-based care models, Pennant can capitalize on this trend by participating in accountable care organizations (ACOs) and other value-based payment arrangements. By demonstrating its ability to deliver high-quality care at a lower cost, Pennant can attract new patients, improve its reimbursement rates, and enhance its reputation. This includes implementing care coordination programs, focusing on preventive care, and measuring patient outcomes. The timeline for this growth is ongoing, with a focus on aligning incentives and improving care delivery.

What Are PNTG's Competitive Advantages?

  • Geographic diversification across 14 states reduces reliance on any single market.
  • Integrated service offerings across home health, hospice, and senior living provide comprehensive care solutions.
  • Established relationships with healthcare providers and payers enhance market access.

What Does PNTG Do?

The Pennant Group, Inc., incorporated in 2019 and headquartered in Eagle, Idaho, provides a range of healthcare services across the United States. The company operates through two primary segments: Home Health and Hospice Services, and Senior Living Services. The Home Health and Hospice Services segment delivers clinical services such as nursing, speech therapy, occupational therapy, physical therapy, medical social work, and home health aide services. Additionally, it offers hospice care, including clinical care, education, and counseling for terminally ill patients and their families, addressing their physical, spiritual, and psychosocial needs. The Senior Living Services segment provides residential accommodations, activities, meals, housekeeping, and assistance with daily living activities to seniors who are either independent or require support. As of December 2021, Pennant operated 88 home health and hospice agencies and 54 senior living communities with 4,127 units across Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. Pennant's integrated approach aims to provide comprehensive care solutions, positioning it as a key player in the expanding healthcare services market.

What Products and Services Does PNTG Offer?

  • Provides home health services, including nursing and therapy.
  • Offers hospice care for terminally ill patients and their families.
  • Operates senior living communities with residential accommodations.
  • Provides assistance with activities of daily living for seniors.
  • Offers clinical care, education, and counseling services.
  • Provides medical social work and home health aide services.

How Does PNTG Make Money?

  • Generates revenue from home health and hospice services through Medicare, Medicaid, and private insurance reimbursements.
  • Earns revenue from senior living services through resident fees and service charges.
  • Expands through strategic acquisitions and organic growth of agencies and communities.

What Industry Does PNTG Operate In?

The Pennant Group, Inc. operates in the healthcare services industry, which is characterized by increasing demand driven by an aging population and a growing preference for home-based and community-based care. The market is fragmented, with numerous regional and national players. Pennant's focus on integrated home health, hospice, and senior living services positions it to capitalize on the trend towards comprehensive care solutions. The industry is also subject to regulatory scrutiny and reimbursement pressures, requiring companies to maintain high standards of compliance and operational efficiency.

Who Are PNTG's Key Customers?

  • Seniors requiring residential accommodations and assistance with daily living.
  • Terminally ill patients and their families seeking hospice care.
  • Individuals requiring home health services due to illness, injury, or disability.
Model self-rating on this text: 73% (not a measure of the evidence) Updated: May 10, 2026

Research confidence

High 100/100

Broad, current evidence sits behind this analysis.

  • Scored on 100% of our measures
  • Price is current
  • Latest filing 37 days ago
  • Covered by analysts

Why 69?

Measured against companies in the same sector. The figures below are the factor contributions the scoring engine itself produced.

What is helping

  • +0.41 Financial-health checklist (Financial Strength)
  • +0.41 Revenue growth (Growth)
  • +0.38 Return on equity (Business Quality)

What is holding it back

  • -0.60 Net debt vs earnings (Financial Strength)
  • -0.60 Debt to equity (Financial Strength)
  • -0.14 Enterprise value vs free cash flow (Valuation)

Contribution = how far the company sits from its sector on that measure, weighted by how much the pillar counts. Not investment advice. How the score is built →

MoonshotScore History

Recorded daily since 2026-08-23 · 19 snapshots

2026-08-23 71
2026-08-26 72
2026-08-29 72
2026-09-01 69
2026-09-04 69
2026-09-07 68
2026-09-10 69

What changed?

The grade moved from 71 to 69 (-2).

What moved it up or down:

  • -18 Valuation
  • -3 Financial Strength

Held back by:

  • +9 Momentum
  • +1 Growth

Over the same 18 days the stock moved +0.5%.

The Pennant Group, Inc. (PNTG) Valuation Context

Valued at $1.36B, PNTG is classified as a small-cap stock. Analyst price targets span from $40.00 to $48.00, with a consensus of $44.50. At the current price of $39.07, that implies approximately 14% upside potential. Relative to its peer group, PNTG's quantitative score of 69/100 is roughly in line with the peer average of 66/100.

PNTG Revenue & Earnings Trend

In Q2 FY2026, PNTG generated $298.0M in top-line revenue, marking a sequential increase of 4.4%. The company recorded net income of $9.1M, with diluted EPS of $0.25. Quarter-over-quarter revenue has been mixed, typical for a small-cap company operating in Healthcare. Across the four most recent quarters, PNTG averaged $0.23 in diluted EPS.

Company Profile

The Pennant Group, Inc. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Eagle, US. The company is led by CEO Brent J. Guerisoli. PNTG has traded publicly since 2019.

ROE 10%

Key Financial Metrics

Return on equity for The Pennant Group, Inc. stands at 9.5%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 3.1%, showing how much profit it generates from its asset base. PNTG trades at a trailing price-to-earnings ratio of 41.81, above the Healthcare sector average of ~21.50x. Its free cash flow yield is 1.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.20 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 2.4%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 6/9

Financial Health

The Pennant Group, Inc.'s Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 2.71 places it in the grey zone, a middle ground that warrants monitoring.

7/8 beats

Earnings Track Record

The Pennant Group, Inc. has beaten Wall Street's EPS estimate in 7 of its last 8 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 8.1% above estimates on average.

Net buying

Insider Activity

Over the past six months, The Pennant Group, Inc. insiders filed 28 SEC Form 4 transactions — 13 sales and 15 purchases. On net that is roughly 4K shares acquired (about $690K) — insiders putting money in tends to read as conviction.

PNTG Financials

Fundamental Snapshot

Revenue Growth (FY)
+36.3%
Net Income Growth (FY)
+31.1%
EPS Growth (FY)
+19.4%
Free Cash Flow Growth (FY)
-13.2%
P/E (TTM)
41.81
Return on Equity (TTM)
+9.5%
Current Ratio
1.2
EV/EBITDA (TTM)
27.8

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Diversified service offerings across home health, hospice, and senior living.
  • Geographic presence in multiple states.
  • Experienced management team with a track record of growth.
  • Strong relationships with healthcare providers and payers.

Bear Case

  • Relatively low gross and profit margins compared to industry peers.
  • High reliance on government reimbursements.
  • Exposure to regulatory changes and compliance risks.
  • Competition from larger, more established players.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · September 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q2 FY2026 $298M $9M $0.25
Q1 FY2026 $285M $9M $0.24
Q4 FY2025 $289M $9M $0.24
Q3 FY2025 $229M $6M $0.17

Q2 FY2026 · filed 5 Aug 2026 · SEC EDGAR →

Based on FMP financials and quantitative analysis

PNTG Latest News

PNTG Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for PNTG.

Price Targets

Low
$40.00
Consensus
$44.50
High
$48.00

Median: $45.00 (+13.9% from current price)

Source: FMP analyst consensus · as of Aug 25, 2026 · an estimate, not advice

PNTG MoonshotScore

69/100

What does this score mean?

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. PNTG scores 69/100 (Grade B+): the number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Latest The Pennant Group, Inc. Analysis

Leadership: Brent J. Guerisoli

Chief Executive Officer

Brent J. Guerisoli serves as the Chief Executive Officer of The Pennant Group, Inc. His career spans various leadership roles within the healthcare industry, demonstrating expertise in operational management and strategic development. Guerisoli's background includes a strong emphasis on improving patient care and driving organizational growth. He has been instrumental in implementing innovative healthcare solutions and fostering a culture of excellence within Pennant. His leadership is characterized by a focus on sustainable growth and enhanced shareholder value.

Track Record: Under Brent J. Guerisoli's leadership, The Pennant Group, Inc. has experienced significant growth in its home health, hospice, and senior living segments. He has overseen the successful integration of numerous acquisitions, expanding the company's geographic footprint and service offerings. Guerisoli has also focused on improving operational efficiencies and enhancing the quality of care, contributing to Pennant's strong reputation in the healthcare industry.

The Pennant Group, Inc. Healthcare Stock: Key Questions Answered

What does the AI Score mean for PNTG?

PNTG holds an AI Score of 69/100 (Grade: B+). This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers. The Pennant Group, Inc. provides healthcare services, including home health, hospice, and senior living, across 14 states.

Is PNTG a good stock?

Stock Expert AI does not rate PNTG buy, sell or hold. The Pennant Group, Inc. carries a MoonshotScore of 69/100 on the five-pillar engine, a research rating against its peers. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.

What does The Pennant Group, Inc. do?

The Pennant Group, Inc. operates in the healthcare services sector, providing a range of services including home health, hospice, and senior living.

What do analysts say about PNTG stock?

Analyst coverage of The Pennant Group, Inc. (PNTG) typically focuses on its growth prospects within the healthcare services industry, particularly in the home health, hospice, and senior living segments.

What are the key factors to evaluate for PNTG?

The Pennant Group, Inc. (PNTG) holds an AI score of 69/100 (moderate). P/E: 41.81x vs the S&P 500's ~20-25x. Analysts target $44.50 (+14%). Not financial advice.

How frequently does PNTG data refresh on this page?

PNTG's price was last updated on Sep 10, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven PNTG's recent stock price performance?

The Pennant Group, Inc. (PNTG) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified service offerings across home health, hospice, and senior living. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider PNTG overvalued or undervalued right now?

The Pennant Group, Inc. (PNTG) trades at 41.81x earnings. Analysts target $44.50 (+14%) — upside seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of PNTG?

Yes, most major brokerages offer fractional shares of The Pennant Group, Inc. (PNTG) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated MoonshotScore as of
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on available data as of 2021 and 2026-05-10. Future performance may vary.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

More Stocks We Cover